Last year sales of Lipitor up but Neurontin down.

Jeil Pharmaceutical company reported 2005 business performance that Lipitor sales rose 47.09% in 2005 at 64,125 MW following 34.24% up in 2004 over the previous year, showing a sharp rise during the past two consecutive years.

However, the figure of Neurontin showed a slight decline by 29.96% at 31,049 MW in 2005 over 41,938 MW in 2004 when 42.34% growth over 2003 was achieved.

Overall s...